Alipay+ and Kaspi.kz Enhance International Payment Acceptance in Kazakhstan
13.8.2025 07:01:00 CEST | Business Wire | Press release
Kazakhstan becomes the first country in Central Asia to accept Alipay+, enabling local merchants to accept payments from international e-wallets and bank appsThis builds on the earlier partnership enabling Kazakhstanis to use Kaspi.kz to make payments overseas via Alipay+
Alipay+, Ant International’s global wallet gateway, and Kaspi.kz, the leading super app in Kazakhstan, have enabled international cross-border QR payment acceptance in Kazakhstan. Users of 12 Alipay+-enabled payment apps can scan-to-pay via Kaspi QR, which has the largest nationwide merchant coverage, from shopping, F&B and attractions, to convenience stores, medical services and even stores in smaller villages and towns.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250812116781/en/

Alipay+ partners can scan at Kaspi.kz merchants across Kazakhstan
Kazakhstan becomes the first country in Central Asia to accept Alipay+, enabling local merchants to leverage the country’s digital payment infrastructure to benefit from tourism growth by accepting more international payment options. In the first half of 2025, Kazakhstan welcomed a record 7.5 million international visitors. Travellers from China, Germany and South Korea are amongst the top five arrivals to Kazakhstan, and they can now use their Alipay+-enabled app to make seamless payment.
Edward Yue, General Manager for SEA, South Asia and ANZ, Ant International said, “We’re very excited to be strengthening our partnership with Kaspi.kz for both inbound and outbound cross-border mobile payments that benefits Kazakhstani travellers and businesses. We have seen great momentum in Kazakhstanis using their Kaspi.kz app across our global Alipay+ merchants, and now we’re building on the rich local ecosystem offered via Kaspi QR to connect our global partners to local businesses. As more people seek culturally rich and unique destinations, we will continue to work closely to promote vibrant and sustainable growth in Kazakhstan and the region.”
This builds on the successful partnership between Alipay+ and Kaspi.kz for outbound cross-border mobile payments, since April 2024. Top destinations for Kazakhstanis include China, Japan, South Korea and Southeast Asia, to Australia, Italy and France.
Mikhail Lomtadze, CEO and Co-founder of Kaspi.kz, said, “Since last year, in partnership with Alipay+, Kazakhstanis began to pay in some of their favourite travel destinations using the Kaspi.kz super app. Now, we’re taking our partnership one step further. Guests visiting Kazakhstan can now pay via Kaspi QR using their Alipay+ enabled e-wallets or bank apps. We thank Alipay+ for the opportunity to work together to make travel to Kazakhstan more convenient, and jointly promote growth.”
Alipay+ connects 1.7 billion user accounts from 36 international payment partners to more than 100 million merchants across 70 markets.
About Alipay+
Ant International’s Alipay+ is a Unified Gateway with cross-border payment and digitisation services that help connect global merchants to consumers. Consumers enjoy seamless payment, a broad choice of deals and the convenience of digital services using their preferred payment app while travelling abroad. Small and medium-sized businesses may use Alipay+ digital tools to enhance efficiency and achieve omni-channel growth.
About Kaspi.kz
Kaspi.kz’s mission is to improve people’s lives by developing innovative mobile products and services. To deliver upon this we operate a unique two-sided Super App model – Kaspi.kz Super App for consumers and Kaspi Pay Super App for merchants.
Through these Super Apps consumers and merchants can access our leading Payments, Marketplace, and Fintech Platforms. All our services are designed to be highly relevant to users’ everyday needs and enable consumers and merchants to connect and transact between themselves.
The combination of a large, highly engaged consumer and merchant base, best-in-class, highly relevant digital products and a capex lite approach, results in strong top-line growth, a profitable business model and enables us to continue innovating, delighting our users and fulfilling our mission.
In January 2025, Kaspi.kz acquired a 65.41% stake in Hepsiburada, one of the leading e-commerce companies in Türkiye.
Harvard Business School has written two case studies on Kaspi.kz which it continues to teach to its MBA students.
Kaspi.kz has been listed on Nasdaq since January 2024.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250812116781/en/

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte’s Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi®/Minjuvi®) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBCL30.5.2026 14:00:00 CEST | Press release
The Phase 3 frontMIND study evaluated tafasitamab (Monjuvi®/Minjuvi®) and lenalidomide in addition to R-CHOP, the current standard of care, compared with R-CHOP alone in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL)Positive trends toward progression-free survival (PFS) benefit with tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypesThe frontMIND data support the submission of global regulatory applications for tafasitamab and lenalidomide added to R-CHOP for previously untreated DLBCLThe data are being presented in an oral session at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting and simultaneously published in The Lancet* Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating t
Fortegra Completes Acquisition by DB Insurance29.5.2026 22:30:00 CEST | Press release
The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline. Agents, distribution partners, and customers will continue to experience the service excellence that has defined the Fortegra experience. Richard Kahlbaugh, Chairman and CEO of Fortegra, said: "Every company eventually changes ownership. That is the nature of business. The closing of this acquisition is a starting point. As part of DB Insurance, Fortegra is positioned to expand our business geographically, enhance our capabilities and deepen our market presence in the US, Europe, the United Kingdom and Asia. Together, DB Insurance a
SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 22:01:00 CEST | Press release
Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom